3,000
Participants
Start Date
December 15, 2023
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Follow up
Each subject was recruited in 30-60 days after the last dose of domestic bivalent HPV vaccine or imported HPV vaccine, and followed up at 12 months (window period ± 1 month) and 36 months (window period ± 1 month) after the last dose of domestic bivalent HPV vaccine or imported HPV vaccine, with a total of two follow-up visits. At enrollment and both follow-up visits, subjects were required to collect 2 tubes of peripheral venous blood each.
Fujian Maternity and Child Health Hospital, Fuzhou
Fujian Maternity and Child Health Hospital
OTHER